NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...

NeueHealth, Inc. (NYSE:NEUE) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President and CEO Jay Matushak - CFO Conference Call Participants Operator Ladies and gentlemen, welcome to the NeueHealth Third Quarter 2024 Earnings Call. My name is Kenneth, and I will be coordinating your call today. I will now hand you over to your host, Emily Lombardi to begin. Please go ahead. Emily Lombardi Good morning, and welcome to ...

NeueHealth, Inc. (NYSE:NEUE) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President and CEO Jay Matushak - CFO Conference Call Participants Operator Ladies and gentlemen, welcome to the NeueHealth Third Quarter 2024 Earnings Call. My name is Kenneth, and I will be coordinating your call today. I will now hand you over to your host, Emily Lombardi to begin. Please go ahead. Emily Lombardi Good morning, and welcome to ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value NEUE New York Stock Exchange (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 NEUEHEALTH, INC. (Exact Name of Registra ...

Exhibit 99.1 NEUEHEALTH REPORTS THIRD QUARTER 2024 RESULTS • Delivered strongest financial performance to date in Q3 '24, resulting from continued positive momentum in NeueCare and NeueSolutions business segments • Drove positive Adjusted EBITDA for the third consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year • Well-positioned to build on success and capitalize on strategic growth opportunities in 2025 and beyond † DORAL, Fla. (November 7, 2024) (BUSINESSWIRE) – NeueHealth, ...

NeueHealth (NEUE) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Since a changing ear ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value NEUE New York Stock Exchange (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 NEUEHEALTH, INC. (Exact Name of Registrant as ...

| --- | --- | --- | --- | --- | |----------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | NeueHealth Second Quarter 2024 - Earnings Presentation | | | | | | Privileged & Confidential \| © 2024 August 7, 2024 | | | | | Disclaimer Statements made in this presentation that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward- ...

NeueHealth, Inc. (NYSE:NEUE) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Conference Call Participants Operator Good morning, all. Welcome to the NeueHealth Q2 2024 Earnings Call. My name is Karli, and I'll be your call coordinator today. I would like to hand over to your host, Emily Lombardi. Please begin. Emily Lombardi Good morning, and welcome to ...

Exhibit 99.1 NEUEHEALTH REPORTS SECOND QUARTER 2024 RESULTS | --- | --- | --- | |------------------------------------|-----------------------|------------| | Key Metrics | As of June \n2024 | 30, \n2023 | | Consumer and Patient Metrics | | | | Value-Based Consumers served | 364,000 | 373,000 | | Enablement Services Lives | 113,000 | 31,000 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------|-------|---------------------|----------------|------- ...